BRAIN MONOAMINES AND LUTEINIZING HORMONE SECRETION
脑单胺和黄体生成素的分泌
基本信息
- 批准号:3312271
- 负责人:
- 金额:$ 10.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-12-01 至 1990-01-31
- 项目状态:已结题
- 来源:
- 关键词:6 hydroxydopamine brain metabolism denervation dopamine epinephrine estradiol high performance liquid chromatography hormone regulation /control mechanism laboratory rat luteinizing hormone neurochemistry neuroendocrine system neuropeptide Y neurotoxins neurotransmitter metabolism norepinephrine optics pituitary gonadal axis progesterone prolactin radioimmunoassay radiotracer serotonin sympathetic nervous system thin layer chromatography tritium
项目摘要
The objective is to examine the neural mechanisms by which the ovarian
hormones, estradiol and progesterone, regulate the secretion of luteinizing
hormone (LH) from the anterior pituitary gland. The experiments will test
the hypothesis that the inhibitory and stimulatory feedback actions of the
ovarian hormones are mediated in part via changes in the activity of
noradrenergic and adrenergic neural systems that control the neurosecretion
of LH-releasing hormone (LHRH). It is proposed that estradiol and
progesterone affect activity in intrahypothalamic neuronal systems, such as
the endogenous opioid neuropeptides and Gamma-aminobutyric acid, which
regulate catecholamine release, and of neuropeptide Y (NPY), which
modulates the response of the pituitary gland to LHRH. To test this
hypothesis further, discrete hypothalamic areas will be incubated
understatic or perifusion conditions in vitro. The release of LHRH and NPY
into the medium will be measured by radioimmunoassays, while catecholamines
will be measured by radioenzymatic assay. The first group of experiments
will examine the postsynaptic mechanisms, especially the involvement of the
Ca++ messenger system, mediating the stimulatory effect of norepinephrine
(NE), epinephrine (EPI) and NPY on LHRH release. These studies will also
test whether NPY alters the response of LHRH neurons to the
catecholamines. A second set of studies will examine the interaction of
NPY with the catecholamines in the regulation of LHRH release, and in
particular, will test whether NE or EPI stimulates the release of NPY. A
third set of studies will test whether the inhibitory effects of low dosage
E2 treatment in vivo on the release of LHRH in vitro is due to activation
of opioid systems that depress the release of NE and NPY. Other
experiments will test whether the effect of in vitro progesterone to
stimulate LHRH release is mediated by increased release of NE, EPI or NPY,
and whether this can be inhibited by opioid or by GABA agonists. A fourth
set of studies will test further the mechanisms underlying the facilitation
of LHRH-induced LH release by NPY, using dispersed anterior pituitary cells
in culture.
目的是研究卵巢癌的神经机制,
激素,雌二醇和孕酮,调节促黄体生成激素的分泌,
垂体前叶分泌的促黄体生成素(LH)。 实验将测试
这一假说认为,抑制性和刺激性的反馈行动,
卵巢激素部分是通过改变
控制神经分泌的去甲肾上腺素能和肾上腺素能神经系统
LH释放激素(LHRH)。 有人提出,雌二醇和
孕酮影响下丘脑内神经元系统的活性,例如
内源性阿片类神经肽和γ-氨基丁酸,
调节儿茶酚胺的释放,以及神经肽Y(NPY),
调节脑下垂体对LHRH的反应。 为了验证这一
进一步假设,离散的下丘脑区域将被孵育
在体外静态或灌流条件下。 LHRH和NPY的释放
将通过放射免疫测定法测量进入培养基的量,而
将通过放射酶测定法进行测量。 第一组实验
将研究突触后机制,特别是参与
Ca++信使系统,介导去甲肾上腺素的刺激作用
(NE)、肾上腺素(EPI)和NPY对LHRH释放的影响。 这些研究还将
测试NPY是否改变LHRH神经元对
儿茶酚胺 第二组研究将探讨
在LHRH释放的调节中,NPY与儿茶酚胺一起起作用,
特别是,将测试NE或EPI是否刺激NPY的释放。 一
第三组研究将测试低剂量的抑制作用是否
E2在体内处理对体外LHRH释放的影响是由于激活
阿片系统抑制NE和NPY的释放。 其他
实验将测试是否在体外孕酮的效果,
刺激LHRH释放通过增加NE、EPI或NPY的释放来介导,
以及这是否可以被阿片类药物或GABA激动剂抑制。 第四
一组研究将进一步测试促进的机制
LHRH诱导的LH释放的NPY,使用分散的垂体前叶细胞
在文化中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM R CROWLEY其他文献
WILLIAM R CROWLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM R CROWLEY', 18)}}的其他基金
BRAIN MONOAMINES AND LUTEINIZING HORMONE SECRETION
脑单胺和黄体生成素的分泌
- 批准号:
6140485 - 财政年份:1999
- 资助金额:
$ 10.04万 - 项目类别:
相似海外基金
Brain metabolism across the lifespan using multi-parametric MRS
使用多参数 MRS 分析整个生命周期的脑代谢
- 批准号:
10738647 - 财政年份:2023
- 资助金额:
$ 10.04万 - 项目类别:
Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging
量化基于任务的 BOLD 成像背后的大脑代谢
- 批准号:
10432379 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别:
Novel 10.5 T deuterium-based MRS/I method to measure brain metabolism
测量脑代谢的新型 10.5 T 氘 MRS/I 方法
- 批准号:
10442075 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别:
Neuroimaging study of the effects of phospholipase A2 (PLA2) inhibition on brain metabolism and neuroinflammation in a rat model of Alzheimer’s Disease.
神经影像学研究磷脂酶 A2 (PLA2) 抑制对阿尔茨海默病大鼠模型脑代谢和神经炎症的影响。
- 批准号:
486273 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别:
Studentship Programs
Dynamics of Cellular Brain Metabolism Using Mass Spectrometry Imaging
使用质谱成像研究细胞脑代谢动力学
- 批准号:
10556434 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别:
In vivo MRI Measures of Brain Metabolism in Traumatic Brain Injury
创伤性脑损伤中脑代谢的体内 MRI 测量
- 批准号:
10444479 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别:
Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging
量化基于任务的 BOLD 成像背后的大脑代谢
- 批准号:
10816746 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别:
Dynamics of cellular brain metabolism using mass spectrometry imaging
使用质谱成像研究细胞脑代谢动力学
- 批准号:
10418219 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别:
Brain metabolism during task-evoked and spontaneous activity in aging and Alzheimer's disease
衰老和阿尔茨海默病中任务诱发和自发活动期间的大脑代谢
- 批准号:
10585419 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
PhytoSERM 预防更年期相关脑代谢和认知能力下降的功效:双盲、随机、安慰剂对照 2 期临床试验
- 批准号:
10560591 - 财政年份:2022
- 资助金额:
$ 10.04万 - 项目类别: